Comparative Effects of Artesunate, Clindamycin and Their Combination on Parasitaemia, Body Weight and Open-Field Behaviour in Plasmodium berghei ANKA-Infected Wistar Rats

Authors:

Abstract
Malaria treatment studies often infer efficacy from parasite clearance, although functional responses may follow different trajectories. This study compared artesunate, clindamycin and their combination in Plasmodium berghei ANKA-infected Wistar rats. Sixty-four rats were allocated equally to eight infected or uninfected groups receiving vehicle, artesunate (4 mg/kg/day intraperitoneally), clindamycin (10 mg/kg/day orally), or both drugs on Days 3–7 post-inoculation. Day 3 assessments preceded the first dose. Parasitaemia was monitored on Days 3–8 in infected rats; body weight and open-field line crossing, rearing and grooming were also evaluated. Parasitaemia showed a significant time-by-treatment interaction (Greenhouse–Geisser F (9.643, 89.998) = 366.461, p < 0.001, partial η² = 0.975). Artesunate produced microscopically undetectable parasitaemia by Day 6, whereas clindamycin and the combination did so by Day 7. Mean Day 3–8 parasitaemia area under the curve was 45.65 ± 1.16 %-days with infected vehicle, 8.01 ± 0.22 with artesunate, 9.27 ± 0.46 with clindamycin and 7.44 ± 0.31 with combination therapy (Welch F (3, 14.442) = 2547.698, p < 0.001); every pairwise comparison was significant. Time-by-group interactions were significant for line crossing, rearing and grooming, but the combination showed no consistent behavioural advantage. Day 7 body weight differed among groups after adjustment for Day 3 weight (F (7, 55) = 4.703, p < 0.001). All animals reached the scheduled Day 8 endpoint. Artesunate provided the earliest microscopic clearance, while the combination modestly reduced cumulative parasite exposure without demonstrating pharmacological synergy or uniform behavioural benefit.